This paper analyzes some of the perverse incentives that may arise under the current
Medicare prescription drug benefit design. In particular, risk adjustment for a standalone …

Faced with relentless growth in pharmaceutical spending during the 1990s, health plans in
recent years have tried to rein in costs by negotiating lower drug prices, encouraging more …

Introduction: Poor prescription drug adherence is common, jeopardizing the benefits of
treatment and increasing the costs of health care in the United States. A frequently reported …

Objective. To estimate the effect of two separate policy changes in the North Carolina
Medicaid program:(1) reduced prescription lengths from 100 to 34 days' supply, and (2) …

Results: After policy# 1, target generic use increased by 0.93%(P< 0.001) with a subsequent
quarterly slope decrease of− 0.16%(P< 0.01); policy# 2 led to a slope increase of 0.20%(P< …

This report summarizes the literature on different financial mechanisms used to provide
patient access to prescription drugs. The report recaps government funding mechanisms for …

OBJECTIVE: To evaluate the effect of a closed formulary on pharmaceutical utilization and
expenditures in a noncontinuously eligible population. DESIGN: A pretest-posttest design …

OBJECTIVES: This paper investigates the pricing strategy (perfect flat pricing, perfect
monotonic pricing, intermediate) used for multiple dosage medications listed in the Ontario …

This study estimates the impact of patient financial incentives on the use and cost of
prescription drugs in the context of differing physician payment mechanisms. A large data …

This study estimates the effects of an increase in an outpatient prescription drug copayment
using a natural experiment based upon a large firm that implemented such an increase. The …